Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage i lung cancer in the elderly

M. Shapiro, G. Mhango, Max Kates, T. S. Weiser, C. Chin, S. J. Swanson, J. P. Wisnivesky

Research output: Contribution to journalArticle

Abstract

Background & objectives: Pathologic evaluation of >10 lymph nodes (LNs) is considered necessary for accurate lung cancer staging. However, physicians have concerns about increased risk in perioperative mortality (POM) and morbidity with more extensive LN sampling, particularly in the elderly. In this study, we compared the outcomes in elderly patients with stage I non-small cell lung cancer (NSCLC) undergoing extensive (>10 nodes) and limited (≤10 nodes) LN resections. Methods: Using data from the Surveillance, Epidemiology and End Results registry linked to Medicare records, we identified 4975 patients ≥65 years of age with stage I NSCLC who underwent a lobectomy between 1992 and 2002. Risk of perioperative morbidity and POM after the evaluation of ≤10 vs. >10 LNs was compared among patients after adjusting for propensity scores. Results: Multiple regression analysis showed similar POM between the two groups (OR, 1,01; 95% CI, 0,71-1,44). Other postoperative complications were similar across groups except for thromboembolic events, which were more common among patients undergoing resection of >10 LNs (OR, 1,72; 95% CI, 1,12-2,63). Conclusions: These data suggest that evaluation of >10 LNs, which allows for more accurate staging, appears to be safe in the elderly patients undergoing lobectomy for stage I NSCLC without compromising postoperative recovery.

Original languageEnglish (US)
Pages (from-to)516-522
Number of pages7
JournalEuropean Journal of Surgical Oncology
Volume38
Issue number6
DOIs
StatePublished - Jun 1 2012

Fingerprint

Lung Neoplasms
Lymph Nodes
Morbidity
Mortality
Non-Small Cell Lung Carcinoma
Propensity Score
Neoplasm Staging
Medicare
Registries
Epidemiology
Regression Analysis
Physicians

Keywords

  • Elderly
  • Lung cancer
  • Lymph nodes
  • Morbidity
  • Mortality
  • Resection

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage i lung cancer in the elderly. / Shapiro, M.; Mhango, G.; Kates, Max; Weiser, T. S.; Chin, C.; Swanson, S. J.; Wisnivesky, J. P.

In: European Journal of Surgical Oncology, Vol. 38, No. 6, 01.06.2012, p. 516-522.

Research output: Contribution to journalArticle

Shapiro, M. ; Mhango, G. ; Kates, Max ; Weiser, T. S. ; Chin, C. ; Swanson, S. J. ; Wisnivesky, J. P. / Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage i lung cancer in the elderly. In: European Journal of Surgical Oncology. 2012 ; Vol. 38, No. 6. pp. 516-522.
@article{e0f10587fe28419497c9e05c9fc6a7f0,
title = "Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage i lung cancer in the elderly",
abstract = "Background & objectives: Pathologic evaluation of >10 lymph nodes (LNs) is considered necessary for accurate lung cancer staging. However, physicians have concerns about increased risk in perioperative mortality (POM) and morbidity with more extensive LN sampling, particularly in the elderly. In this study, we compared the outcomes in elderly patients with stage I non-small cell lung cancer (NSCLC) undergoing extensive (>10 nodes) and limited (≤10 nodes) LN resections. Methods: Using data from the Surveillance, Epidemiology and End Results registry linked to Medicare records, we identified 4975 patients ≥65 years of age with stage I NSCLC who underwent a lobectomy between 1992 and 2002. Risk of perioperative morbidity and POM after the evaluation of ≤10 vs. >10 LNs was compared among patients after adjusting for propensity scores. Results: Multiple regression analysis showed similar POM between the two groups (OR, 1,01; 95{\%} CI, 0,71-1,44). Other postoperative complications were similar across groups except for thromboembolic events, which were more common among patients undergoing resection of >10 LNs (OR, 1,72; 95{\%} CI, 1,12-2,63). Conclusions: These data suggest that evaluation of >10 LNs, which allows for more accurate staging, appears to be safe in the elderly patients undergoing lobectomy for stage I NSCLC without compromising postoperative recovery.",
keywords = "Elderly, Lung cancer, Lymph nodes, Morbidity, Mortality, Resection",
author = "M. Shapiro and G. Mhango and Max Kates and Weiser, {T. S.} and C. Chin and Swanson, {S. J.} and Wisnivesky, {J. P.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1016/j.ejso.2011.12.018",
language = "English (US)",
volume = "38",
pages = "516--522",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage i lung cancer in the elderly

AU - Shapiro, M.

AU - Mhango, G.

AU - Kates, Max

AU - Weiser, T. S.

AU - Chin, C.

AU - Swanson, S. J.

AU - Wisnivesky, J. P.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background & objectives: Pathologic evaluation of >10 lymph nodes (LNs) is considered necessary for accurate lung cancer staging. However, physicians have concerns about increased risk in perioperative mortality (POM) and morbidity with more extensive LN sampling, particularly in the elderly. In this study, we compared the outcomes in elderly patients with stage I non-small cell lung cancer (NSCLC) undergoing extensive (>10 nodes) and limited (≤10 nodes) LN resections. Methods: Using data from the Surveillance, Epidemiology and End Results registry linked to Medicare records, we identified 4975 patients ≥65 years of age with stage I NSCLC who underwent a lobectomy between 1992 and 2002. Risk of perioperative morbidity and POM after the evaluation of ≤10 vs. >10 LNs was compared among patients after adjusting for propensity scores. Results: Multiple regression analysis showed similar POM between the two groups (OR, 1,01; 95% CI, 0,71-1,44). Other postoperative complications were similar across groups except for thromboembolic events, which were more common among patients undergoing resection of >10 LNs (OR, 1,72; 95% CI, 1,12-2,63). Conclusions: These data suggest that evaluation of >10 LNs, which allows for more accurate staging, appears to be safe in the elderly patients undergoing lobectomy for stage I NSCLC without compromising postoperative recovery.

AB - Background & objectives: Pathologic evaluation of >10 lymph nodes (LNs) is considered necessary for accurate lung cancer staging. However, physicians have concerns about increased risk in perioperative mortality (POM) and morbidity with more extensive LN sampling, particularly in the elderly. In this study, we compared the outcomes in elderly patients with stage I non-small cell lung cancer (NSCLC) undergoing extensive (>10 nodes) and limited (≤10 nodes) LN resections. Methods: Using data from the Surveillance, Epidemiology and End Results registry linked to Medicare records, we identified 4975 patients ≥65 years of age with stage I NSCLC who underwent a lobectomy between 1992 and 2002. Risk of perioperative morbidity and POM after the evaluation of ≤10 vs. >10 LNs was compared among patients after adjusting for propensity scores. Results: Multiple regression analysis showed similar POM between the two groups (OR, 1,01; 95% CI, 0,71-1,44). Other postoperative complications were similar across groups except for thromboembolic events, which were more common among patients undergoing resection of >10 LNs (OR, 1,72; 95% CI, 1,12-2,63). Conclusions: These data suggest that evaluation of >10 LNs, which allows for more accurate staging, appears to be safe in the elderly patients undergoing lobectomy for stage I NSCLC without compromising postoperative recovery.

KW - Elderly

KW - Lung cancer

KW - Lymph nodes

KW - Morbidity

KW - Mortality

KW - Resection

UR - http://www.scopus.com/inward/record.url?scp=84860287671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860287671&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2011.12.018

DO - 10.1016/j.ejso.2011.12.018

M3 - Article

C2 - 22244908

AN - SCOPUS:84860287671

VL - 38

SP - 516

EP - 522

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 6

ER -